74389-77-8Relevant academic research and scientific papers
Diamine beta2 adrenergic receptor agonists
-
Page/Page column 15-16, (2010/02/14)
The invention provides novel β2 adrenergic receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with β2 adrenergic receptor activity, and processes and intermediates useful for preparing such compounds.
Further investigation on methoctramine-related tetraamines: Effects of terminal N-substitution and of chain length separating the four nitrogens on M2 muscarinic receptor blocking activity
Minarini,Budriesi,Chiarini,Melchiorre,Tumiatti
, p. 1167 - 1178 (2007/10/02)
A series of tetraamines related to methoctramine (1) was synthesized and evaluated for its blocking activity on M2 and M3 muscarinic receptors of guinea pip left atria and ileum, respectively. Thus, tetraamines 2-7 were synthesized t
